Guardant Health (GH) Short-term Investments (2017 - 2026)

Guardant Health (GH) has 10 years of Short-term Investments data on file, last reported at $113.5 million in Q1 2026.

• Quarterly Short-term Investments changed N/A year-over-year to $113.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $113.5 million (changed N/A YoY) and the FY2025 annual result came in at $823.4 million, up 161.86% from the prior year.
• Short-term Investments retreated to $113.5 million in Q1 2026 per GH's latest filing, from $823.4 million in the prior quarter.
• The five-year high for Short-term Investments was $953.8 million in Q2 2023, with the low at $35.1 million in Q4 2023.
• Average Short-term Investments over 5 years is $554.9 million, with a median of $668.0 million recorded in 2022.
• Year-over-year, Short-term Investments slumped 95.96% in 2023 and jumped 795.91% in 2024.
• Guardant Health's Short-term Investments stood at $869.6 million in 2022, then tumbled by 95.96% to $35.1 million in 2023, then jumped by 795.91% to $314.4 million in 2024, then soared by 161.86% to $823.4 million in 2025, then slumped by 86.22% to $113.5 million in 2026.
• Business Quant data shows GH's Short-term Investments at $113.5 million in Q1 2026, $823.4 million in Q4 2025, and $314.4 million in Q4 2024.